Surgical Science Sweden AB (publ) (FRA:4P41)

Market Cap	159.90M
Revenue (ttm)	88.19M
Net Income (ttm)	6.32M
Shares Out	n/a
EPS (ttm)	0.12
PE Ratio	25.32
Forward PE	13.50
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,225
Average Volume	139
Open	3.200
Previous Close	2.976
Day's Range	3.148 - 3.200
52-Week Range	2.510 - 17.220
Beta	n/a
RSI	16.84
Earnings Date	Feb 19, 2026

About FRA:4P41

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy tra...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1997
• Employees: 274
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 4P41

Financial Performance

In 2024, FRA:4P41's revenue was 884.09 million, an increase of 0.14% compared to the previous year's 882.85 million. Earnings were 131.65 million, a decrease of -43.73%.

Financial numbers in SEK